Patents by Inventor Sergey Podkovyrov

Sergey Podkovyrov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10471133
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: November 12, 2019
    Assignee: Elanco US Inc.
    Inventors: David M. Anderson, Sergey Podkovyrov, Yuefang Huang, Kurt Schuster, Jon Edward Ferrel
  • Publication number: 20180326020
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 15, 2018
    Inventors: David M. ANDERSON, Sergey PODKOVYROV, Yuefang HUANG, Kurt SCHUSTER, Jon Edward FERREL
  • Patent number: 10029002
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: July 24, 2018
    Assignee: ELANCO US INC.
    Inventors: David M. Anderson, Sergey Podkovyrov, Yuefang Huang, Kurt Schuster, Jon Edward Ferrel
  • Publication number: 20160235823
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 18, 2016
    Inventors: David M. ANDERSON, Sergey PODKOVYROV, Yuefang HUANG, Kurt SCHUSTER, Jon Edward FERREL
  • Patent number: 9326535
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: May 3, 2016
    Assignee: ELI LILLY AND COMPANY
    Inventors: David M. Anderson, Sergey Podkovyrov, Yuefang Huang, Kurt Schuster, Jon Edward Ferrel
  • Publication number: 20140369989
    Abstract: Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an enzyme, such as alkaline phosphatase, that is effective to reduce the amount of a detrimental compound, such as ammonia or phosphorous, that is present in or released from animal waste. Also provided is a method for increasing phosphorus digestion in an animal. Compositions suitable for use in such methods are also described.
    Type: Application
    Filed: February 7, 2013
    Publication date: December 18, 2014
    Inventors: David M. Anderson, Sergey Podkovyrov, Yuefang Huang, Kurt Schuster, Jon Edward Ferrel
  • Patent number: 8263384
    Abstract: Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e.g. T4 frd; Serine Hydroxymethyltransferase genes e.g. glyA; 3-phosphoglycerate dehydrogenase genes e.g. serA; and THF synthase genes e.g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: September 11, 2012
    Assignee: Glaxo Group Limited
    Inventors: David Martin Anderson, Andrew John Collis, Lin Liu, Sergey Podkovyrov, Christopher Preston
  • Publication number: 20090081735
    Abstract: Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e.g. T4 frd; Serine Hydroxymethyltransferase genes e.g. glyA; 3-phosphoglycerate dehydrogenase genes e.g. serA; and THF synthase genes e.g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.
    Type: Application
    Filed: February 5, 2007
    Publication date: March 26, 2009
    Inventors: David Martin Anderson, Andrew John Collis, Lin Liu, Sergey Podkovyrov, Christopher Preston
  • Patent number: 7387893
    Abstract: Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin or a uridine kinase gene and/or a dCTP deaminase gene. In preferred embodiments the constructs comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, the host cells comprise constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e.g. thymidine is also disclosed.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: June 17, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: David Martin Anderson, Lin Liu, Sergey Podkovyrov, Baomin Wang
  • Publication number: 20050009083
    Abstract: Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin or a uridine kinase gene and/or a dCTP deaminase gene. In preferred embodiments the constructs comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, the host cells comprise constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e.g. thymidine is also disclosed.
    Type: Application
    Filed: August 9, 2004
    Publication date: January 13, 2005
    Inventors: David Anderson, Lin Liu, Sergey Podkovyrov, Baomin Wang
  • Patent number: 6777209
    Abstract: Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin or a uridine kinase gene and/or a dCTP deaminase gene. In preferred embodiments the constructs comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, the host cells comprise constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e.g. thymidine is also disclosed.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: August 17, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: David Martin Anderson, Lin Liu, Sergey Podkovyrov, Baomin Wang
  • Publication number: 20020128457
    Abstract: Novel DNA constructs and host cells comprising the same are disclosed. DNA constructs comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for ribonucleotide reductase and thioredoxin. In preferred embodiments, constructs further comprise DNA sequences encoding for thymidylate synthase and/or transcription units comprising sequences encoding for uridine kinase preferably together with dCTP deaminase. In particularly preferred embodiments, host cells comprising constructs having all of the above characteristics wherein the host cell displays repressed or no uracil DNA glycosylase activity. This may be achieved by removal of the host cell ung gene. Use of host cells in the manufacture of pyrimidine deoxyribonucleotides e.g. thymidine is also disclosed.
    Type: Application
    Filed: July 1, 1999
    Publication date: September 12, 2002
    Inventors: DAVID MARTIN ANDERSON, LIN LU, SERGEY PODKOVYROV, BAOMIN WANG